News

FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
MedPage Today3d
Some ADHD Meds Can Cause Significant Weight Loss in Young Kids, FDA Warns
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
US FDA to revise label of ADHD medications to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...
MPR3d
FDA: Weight Loss Risk in Younger ADHD Patients on Extended-Release Stimulants
Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...
clinicaladvisor.com3d
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Close more info about FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk Loading... You’ve read {{metering-count}} of {{metering-total}} articles this month.
KSL5d
FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...